# Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common Cold

> **NCT01092039** · NA · COMPLETED · sponsor: **Xigo Health LLC** · enrollment: 140 (estimated)

## Conditions studied

- Common Cold

## Interventions

- **DIETARY_SUPPLEMENT:** lactoferrin, L-Glutamine and beta-glucans
- **DIETARY_SUPPLEMENT:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01092039
- **Lead sponsor:** Xigo Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2012-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092039, "Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common Cold". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT01092039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*